Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004213090 | SCV003719480 | uncertain significance | not specified | 2024-01-08 | criteria provided, single submitter | clinical testing | The c.779A>T (p.E260V) alteration is located in exon 2 (coding exon 1) of the B3GALT2 gene. This alteration results from a A to T substitution at nucleotide position 779, causing the glutamic acid (E) at amino acid position 260 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |